Evidence map›Paper›PMID 32543706›Full record

Trial reportJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2020

Recombinant Human BMP6 Applied Within Autologous Blood Coagulum Accelerates Bone Healing: Randomized Controlled Trial in High Tibial Osteotomy Patients.

Catharina Chiari, Lovorka Grgurevic, Tatjana Bordukalo-Niksic, Hermann Oppermann, Alexander Valentinitsch, Elena Nemecek, Kevin Staats, Markus Schreiner, Carmen Trost, Alexander Kolb and 8 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Time to consider fracture nonunion an orphan disease? An update into pathophysiology, epidemiology and therapeutic solutions.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Therapeutics for enhancement of spinal fusion: A mini review.Journal of orthopaedic translation · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Catharina ChiariDepartment of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria.
Lovorka GrgurevicLaboratory for Mineralized Tissues, Centre for Translational and Clinical Research, University of Zagreb School of Medicine, Zagreb, Croatia.
Tatjana Bordukalo-NiksicLaboratory for Mineralized Tissues, Centre for Translational and Clinical Research, University of Zagreb School of Medicine, Zagreb, Croatia.
Hermann OppermannGenera Research, Rakov Potok, Croatia.
Alexander ValentinitschDepartment of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria.
Elena NemecekDepartment of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria.
Kevin StaatsDepartment of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria.
Markus SchreinerDepartment of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria.
Carmen TrostDepartment of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria.
Alexander KolbDepartment of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria.
Franz KainbergerDepartment of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria.
Sanja PeharLaboratory for Mineralized Tissues, Centre for Translational and Clinical Research, University of Zagreb School of Medicine, Zagreb, Croatia.
Milan MilosevicDepartment of Environmental and Occupational Health and Sports, School of Public Health, "Andrija Stampar,", University of Zagreb School of Medicine, Zagreb, Croatia.
Snjezana MartinovicSmartMedico, Zagreb, Croatia.
Mihaela PericDepartment for Intracellular Communication, Centre for Translational and Clinical Research, University of Zagreb School of Medicine, Zagreb, Croatia.
T Kuber SampathperForm Biologics Inc., Holliston, MA, USA.
Slobodan VukicevicLaboratory for Mineralized Tissues, Centre for Translational and Clinical Research, University of Zagreb School of Medicine, Zagreb, Croatia.
Reinhard WindhagerDepartment of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-6321-1804
Medical University of Vienna · ATUniversity of Zagreb · HRAgency for Medicinal Products and Medical Devices of Croatia · HRBiolog (United States) · USGenera (Croatia) · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone morphogenetic proteins (BMPs) are potent osteogenic proteins that induce new bone formation in vivo. However, their effect on bone healing in the trabecular bone surfaces remains challenging. We evaluated the safety and efficacy of recombinant human BMP6 (rhBMP6) applied within an autologous blood coagulum (ABC) in a surgically created wedge defect of the proximal tibia in patients undergoing high tibial osteotomy (HTO) for varus deformity and medial osteoarthritis of the knee. We enrolled 20 HTO patients in a randomized, placebo-controlled, double-blinded phase I/II clinical trial. RhBMP6/ABC (1.0 mg/10 mL ABC prepared from peripheral blood) or placebo (10 mL ABC containing excipients) was administered into the tibial wedge defects. Patients were followed for 0 to 24 months by clinical examination (safety) and computed tomography (CT) and serial radiographic analyses (efficacy). The results show that there were no detectable anti-rhBMP6 antibodies in the blood of any of the 20 patients at 14 weeks after implantation. During the 24 months of follow-up, there were no serious adverse reactions recorded. The CT scans from defects of patients treated with rhBMP6/ABC showed an accelerated bone healing compared with placebo at 9 weeks (47.8 ± 24.1 versus 22.2 ± 12.3 mg/cm

Indexed as

Osteoarthritis, KneeOsteotomyAdultBone Morphogenetic Protein 6FemaleHumansKnee JointMaleMiddle AgedRecombinant ProteinsTibiaBMP6 protein, humanBone Morphogenetic Protein 6Recombinant ProteinsBMPCLINICAL TRIALSIMPLANTSINJURY/FRACTURE HEALING

Identifiers

PMID32543706
PMCPMC7689741
OpenAlexW3035680950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.